Discriminating infection from sterile inflammation: Can radiolabelled antibiotics solve the problem?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 2, 2005, Pages 151-152

  Oyen, Wim J G ^a   Corstens, Frans H M ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTIZOXIME TC 99M; CIPROFLOXACIN F 18; CIPROFLOXACIN TC 99M; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; MONOCLONAL ANTIBODY; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

EDITORIAL; IMAGING SYSTEM; INFECTION; INFLAMMATION; ISOTOPE LABELING; JOINT PROSTHESIS; MEDICAL DECISION MAKING; RADIOISOTOPE DIAGNOSIS; SCINTIGRAPHY; TISSUE INJURY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; DIAGNOSIS, DIFFERENTIAL; FLUORINE RADIOISOTOPES; HUMANS; INFLAMMATION;

EID: 13844289181     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1722-7     Document Type: Editorial

References (15)

1. Boerman OC, Rennen HJJM, Oyen WJG, Corstens FHM. Radiopharmaceuticals to image infection and inflammation. Semin Nucl Med 2001;31:286-95.
2. Palestro CJ, Love C, Tronco GG, Tomas MB. Role of radionuclide imaging in the diagnosis of postoperative infection. Radiographics 2000;20:1649-60.
3. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001;21:1229-38.
4. 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996;347:233-5.
5. Anderson VE, Osheroff N. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. Curr Pharm Des 2001;7:337-53.
6. Pan XS, Yague G, Fisher LM. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob Agents Chemother 2001;45:3140-7.
7. 99mTc. Rev Esp Med Nucl 2000;19:479-83.
8. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J, et al. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med 1997;24:553-6.
9. 99mTc-ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun 2002;23:167-70.
10. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging 2004;31:233-9.
11. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2003;44:920-6.
12. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A. Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol Imaging 2002;29:530-5.
13. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001;42:788-94.
14. 99mTc-ciprofloxacin by different methods and its biodistribution. Appl Radiat Isot 2002;57:193-200.
15. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2004;45:922-3.